WEISER MICHAEL 4
4 · ZIOPHARM ONCOLOGY INC · Filed Dec 11, 2017
Insider Transaction Report
Form 4
WEISER MICHAEL
Director
Transactions
- Exercise/Conversion
Common Stock
2017-12-08$2.73/sh+20,000$54,600→ 225,370 total - Tax Payment
Common Stock
2017-12-08$4.43/sh−12,325$54,600→ 213,045 total - Exercise/Conversion
Stock Option (right to buy)
2017-12-08−20,000→ 0 totalExercise: $2.73Exp: 2017-12-12→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]Represents shares withheld to pay exercise price.
- [F2]6,667 shares vested on each of 12/12/08 and 12/12/09; 6,666 shares vested on 12/12/10.